TIDMCCS
Crossword Cybersecurity PLC
16 March 2021
Crossword Cybersecurity Consulting Division Helps Digital
Healthcare
Start-up Vital Signs Solutions Achieve Cyber Essentials Plus
16 March 2021 - London, UK - Crossword Cybersecurity Plc
(AIM:CCS, "Crossword", the "Company" or the "Group"), the
technology commercialisation company focused on cyber security and
risk management, is today announcing that its consulting division
has helped Vital Signs Solutions , an early-stage, digital
healthcare company, achieve the stringent standards of the UK
Government's Cyber Essentials Plus certification, giving confidence
to its patients, partners and regulators over its data security
processes and protection of sensitive patient data.
Vital Signs Solutions' PocDoc(R) digital platform , was borne
out of a vision of allowing anyone with a smartphone or tablet to
test themselves for a range of major diseases and conditions. The
end-to-end platform facilitates testing for health conditions via a
fingerprick, and provides users with a full health assessment in
minutes, offering solutions to address any health-related issues
that arise. Most recently the PocDoc platform has been providing an
end-to-end Covid-19 rapid testing solution for workplaces across
the UK, allowing employers to enable a workforce to return to work
in a Covid-safe way.
As a rapidly growing digital healthcare company with technology
that has been highlighted by the NHS Digital Accelerator, operated
by DigitalHealth.London as "HealthTech set to transform the NHS", a
strong cyber security stance and the protection of patient data has
always been of critical importance to Vital Signs Solutions.
Working with the Crossword Consulting Team, a full review of every
aspect of security processes and technology was undertaken to
ensure the protection of data from the point of entry for its whole
life, as well as ensure the resilience of the platform against
cyber attacks.
Steve Roest, CEO & Co-founder of Vital Signs Solutions,
said: "As a digital healthcare business, being responsible for
patient data is fundamental to everything we do. The PocDoc
platform is growing rapidly and Cyber Essentials Plus, with its
need for a hands-on technical verification, rather than simple
self-certification, ensures a strong security posture and
foundation for growth that focuses on the trust placed in us by
patients with their data."
Working closely with the board and technical teams at Vital
Signs Solutions, Crossword was able to make a full assessment of
internal networks and processes, before recommending and
implementing where needed in the five key areas covered by Cyber
Essentials Plus: Firewalls and Internet Gateways, Security
Configuration, Access Control, Malware Protection and Patch
Management. These improvements were then independently tested
before certification was awarded. The success of project has been
instrumental in helping Vital Signs Solutions scale as part of the
NHS Digital Accelerator , which supports the uptake and spread of
proven, impactful innovations across England's NHS.
Steve Roest, continued: "Our business is very fast moving and is
developing rapidly. The work of the Crossword team has allowed us
to implement stringent security measures and achieve certification
in a way that doesn't introduce friction into the business and our
processes, that slow us down or make us less agile. The work we
have undertaken will be critical to our success in scaling out our
PocDoc platform across multiple diseases in the UK and beyond."
Chris Wilkinson, Associate Director, Consulting at Crossword
Cybersecurity PLC, added: "Digital health is an exciting high
growth area, where extremely sensitive data is in the care of
companies that are growing extremely fast. Cyber security is
critically important and done well is not a drain on a company's
financial and other resources. Our advice is to get started early
with schemes such as Cyber Essentials Plus and other
accreditations. Not only do they protect your business and the data
under your stewardship, but they also open opportunities."
Contacts
Crossword Cybersecurity plc - Tel: +44 (0) 20 3953 8460
Email: info@crosswordcybersecurity.com
Tom Ilube, Chief Executive Officer
Mary Dowd, Chief Financial Officer
Grant Thornton (Nominated Adviser) - Tel: +44 (0) 20 7383
5100
Colin Aaronson / Jamie Barklem / Lukas Girzadas
Hybridan LLP (Broker) - Tel: +44 (0)203 764 2341
Claire Louise Noyce
For media enquiries contact:
Duncan Gurney, GingerPR
duncan@gingerpr.co.uk - Tel: +44 (0)1932 485 300
About Crossword Cybersecurity plc
Crossword Cybersecurity plc focuses on the development and
commercialisation of university research-based cyber security and
risk management related software and cyber security consulting. The
Group's specialist cyber security product development and software
engineering teams work with its university partners to develop the
research concept into a fully-fledged commercial product that it
will then take to market. The Group's aim is to build up a
portfolio of revenue generating, intellectual property based, cyber
security products. Rizikon Assurance, Crossword's leading product,
is a SaaS platform that enables medium to large companies to assess
and manage all risks from their suppliers. Nixer CyberML,
Crossword's most recently launched product, is a new tool for
businesses that want to solve advanced security and cybercrime
problems, such as detecting and dealing with compromised accounts,
fraud, and in-application denial of service attacks. Crossword's
team of expert cyber security consultants leverages years of
experience in national security, defence and commercial cyber
intelligence and operations to provide bespoke advice tailored to
its clients' business needs.
About Vital Signs Solutions
Vital Signs Solutions is an early-stage, venture backed digital
healthcare company focused on solving major global problems. The
founding team has 30+ years of experience in medical device
diagnostics, organic chemistry, immunology, virology and VC-backed,
fast growth-high-value companies with global scale. The scientific
R+D team has deep expertise in organic chemistry, microfluidics,
blood-based biomarker analysis and image analysis to the highest
level. They have an extensive network of some of the best investors
and advisors across the medtech, digital health and consumer
technology sectors.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAFZGMFDKVGMZM
(END) Dow Jones Newswires
March 16, 2021 03:10 ET (07:10 GMT)
Crossword Cybersecurity (LSE:CCS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Crossword Cybersecurity (LSE:CCS)
Historical Stock Chart
From Apr 2023 to Apr 2024